| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6589508 | LUPIN | Methods and compositions for treating pulmonary disorders using optically pure (R,R) formoterol |
Apr, 2013
(11 years ago) | |
| US6040344 | LUPIN | Formoterol process |
Nov, 2016
(7 years ago) | |
| US7541385 | LUPIN | Bronchodilating β-agonist compositions and methods |
Jun, 2021
(2 years ago) | |
| US7462645 | LUPIN | Bronchodilating beta-agonist compositions and methods |
Jun, 2021
(2 years ago) | |
| US6814953 | LUPIN | Bronchodilating compositions and methods |
Jun, 2021
(2 years ago) | |
| US7348362 | LUPIN | Bronchodilating β-agonist compositions and methods |
Jun, 2021
(2 years ago) | |
| US7473710 | LUPIN | Bronchodilating beta-agonist compositions and methods |
Jun, 2021
(2 years ago) | |
| US6667344 | LUPIN | Bronchodilating compositions and methods |
Jun, 2021
(2 years ago) | |
| US7465756 | LUPIN | Bronchodilating beta-agonist compositions and methods |
Jun, 2021
(2 years ago) | |
| US6720453 | LUPIN | Formoterol tartrate polymorph |
Nov, 2021
(2 years ago) | |
| US8110706 | LUPIN | Formoterol tartrate process and polymorph |
Nov, 2021
(2 years ago) | |
| US6472563 | LUPIN | Formoterol tartrate process and polymorph |
Nov, 2021
(2 years ago) | |
| US7145036 | LUPIN | Formoterol tartrate polymorph |
Nov, 2021
(2 years ago) | |
Brovana is owned by Lupin.
Brovana contains Arformoterol Tartrate.
Brovana has a total of 13 drug patents out of which 13 drug patents have expired.
Expired drug patents of Brovana are:
- US6589508
- US6040344
- US7541385
- US7462645
- US6814953
- US7348362
- US7473710
- US6667344
- US7465756
- US6720453
- US8110706
- US6472563
- US7145036
Brovana was authorised for market use on 06 October, 2006.
Brovana is available in solution;inhalation dosage forms.
Brovana can be used as for the long term treatment, twice daily (morning and evening) maintenance treatment of bronchoconstriction in patients with chronic obstructive pulmonary disease (copd), including chronic bronchitis and emphysema.
The generics of Brovana are possible to be released after 09 November, 2021.
Drugs and Companies using ARFORMOTEROL TARTRATE ingredient
Market Authorisation Date: 06 October, 2006
Treatment: For the long term treatment, twice daily (morning and evening) maintenance treatment of bronchoconstriction in patients with chronic obstructive pulmonary disease (copd), including chronic bronchitis ...
Dosage: SOLUTION;INHALATION
BROVANA family patents
